Fast cognitive decline at the time of dementia diagnosis:: A major prognostic factor for survival in the community

被引:56
作者
Carcaillon, Laure
Peres, Karine
Pere, Jean-Jacques
Helmer, Catherine
Orgogozo, Jean-Marc
Dartigues, Jean-Francois
机构
[1] Univ Victor Segalen, Bordeaux, France
[2] Univ Hosp Ctr, Bordeaux, France
[3] Novartis Pharma SAS, Rueil Malmaison, France
关键词
fast cognitive decline; mortality rate; Alzheimer's disease;
D O I
10.1159/000102017
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background/Aims: Current findings suggest the existence of a category of fast cognitive decliners with a poorer prognosis but better treatment response. Our study aimed at confirming the concept of fast decliners at the time of Alzheimer's disease ( AD) diagnosis which best predicts mortality, in an unselected sample. Methods: 245 incident cases of AD were selected from the French longitudinal cohort PAQUID. We investigated a different threshold of cognitive decline [ measured by the annual loss of points in the Mini Mental State Examination (MMSE) score] to define when a subject could be considered as a fast decliner. We used Cox proportional hazards models to study the relation between cognitive decline and mortality. Results: The significant threshold of decline associated with a higher mortality rate was a loss of 3 points per year in the MMSE score. Among the 245 AD cases, 83 (33.9%) subjects were considered as fast decliners. Of them, 78.3% died during the follow-up compared with 63.0% of the slow decliners (RR = 1.7, 95% CI 1.2-2.5). Conclusion: These results constitute an empirical validation of the concept of fast decliners in community-based AD patients and justify the cutoff of 3 points for the definition of this condition. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 24 条
[1]  
[Anonymous], 1965, MANUEL APPL TEST RET
[2]  
Bassuk SS, 2000, AM J EPIDEMIOL, V151, P676
[3]   THE EFFECTS OF COGNITIVE IMPAIRMENT ON 9-YEAR MORTALITY IN A COMMUNITY SAMPLE [J].
BRUCE, ML ;
HOFF, RA ;
JACOBS, SC ;
LEAF, PJ .
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 1995, 50 (06) :P289-P296
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
DARTIGUES JF, 1991, REV NEUROL-FRANCE, V147, P225
[6]   A method for estimating progression rates in Alzheimer disease [J].
Doody, RS ;
Massman, P ;
Dunn, JK .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :449-454
[7]   Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: Results of a meta-analysis [J].
Farlow, MR ;
Small, GW ;
Quarg, P ;
Krause, A .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 20 (2-3) :192-197
[8]   Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression [J].
Farlow, MR ;
Hake, A ;
Messina, J ;
Hartman, R ;
Veach, J ;
Anand, R .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :417-422
[9]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[10]   CEREBRAL BLOOD-FLOW IN DEMENTIA [J].
HACHINSKI, VC ;
ILIFF, LD ;
ZILHKA, E ;
DUBOULAY, GH ;
MCALLISTER, VL ;
MARSHALL, J ;
RUSSELL, RWR ;
SYMON, L .
ARCHIVES OF NEUROLOGY, 1975, 32 (09) :632-637